ELAN · Elanco Animal Health Inc
$23.67
+1.16 (+5.15%)
At close · Aug 14
Market Cap
$11.83B
Shares
499.62M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 10-Q | 2026-08-05 | 2026-06-30 | |
| 8-K | 2026-08-05 | — | |
| Investor Event Transcript | 2026-06-02 | 2026-06-30 | |
| 8-K | 2026-05-27 | 2026-05-21 | |
| 10-Q | 2026-05-06 | 2026-03-31 | |
| 8-K | 2026-05-06 | — | |
| DEF 14A | 2026-04-08 | 2025-12-31 | |
| 8-K | 2026-02-24 | — | |
| 10-K | 2026-02-24 | 2025-12-31 | |
| 8-K | 2026-01-12 | — | |
| 8-K | 2025-12-09 | 2025-12-05 | |
| 10-Q | 2025-11-05 | 2025-09-30 | |
| 8-K | 2025-11-05 | — | |
| 8-K | 2025-11-03 | 2025-10-31 | |
| 8-K | 2025-08-07 | — | |
| 10-Q | 2025-08-07 | 2025-06-30 | |
| 8-K | 2025-06-26 | 2025-06-25 | |
| 8-K | 2025-05-28 | 2025-05-21 | |
| 8-K | 2025-05-21 | 2025-05-16 | |
| 10-Q | 2025-05-07 | 2025-03-31 | |
| 8-K | 2025-05-07 | — | |
| DEF 14A | 2025-03-27 | 2025-05-16 | |
| 8-K | 2025-03-17 | 2025-03-11 | |
| 10-K | 2025-02-25 | 2024-12-31 | |
| 8-K | 2025-02-25 | — | |
| 8-K | 2025-01-13 | — | |
| 8-K | 2024-11-12 | 2024-11-11 | |
| 8-K | 2024-11-07 | — | |
| 10-Q | 2024-11-07 | 2024-09-30 | |
| 8-K | 2024-10-16 | — | |
| 8-K | 2024-08-13 | — | |
| 10-Q | 2024-08-08 | 2024-06-30 | |
| 8-K | 2024-08-08 | — | |
| 8-K | 2024-07-09 | — | |
| 8-K | 2024-07-03 | — | |
| 8-K | 2024-06-04 | 2024-05-30 | |
| 8-K | 2024-05-08 | — | |
| 10-Q | 2024-05-08 | 2024-03-31 | |
| DEF 14A | 2024-04-19 | 2024-05-30 | |
| 8-K | 2024-04-01 | 2024-03-29 | |
| 8-K | 2024-02-26 | 2024-02-22 | |
| 10-K | 2024-02-26 | 2023-12-31 | |
| 8-K | 2024-02-05 | — | |
| 8-K | 2024-01-08 | — | |
| 8-K | 2024-01-02 | — | |
| 10-Q | 2023-11-07 | 2023-09-30 | |
| 8-K | 2023-11-07 | — | |
| 8-K | 2023-10-04 | — | |
| 8-K | 2023-08-07 | 2023-08-03 | |
| 10-Q | 2023-08-07 | 2023-06-30 |
Showing 1–50 of 133 filings
Key facts
CIK
1739104
CUSIP
28414H103
13F (30d)
495 filings
469 filers
Visit website
Investor relations